Skip to main content

New Products: Jul 2, 2009

Premium

Gentel Biosciences commercially launched its APiX Chromogenic Protein Array system this week. The technology was previously available only in-house for Gentel's custom services business.

The system comprises a scanner with optional analysis software, proprietary surface chemistry substrates, and licensed detection reagents. In a statement, Gentel said the APiX Chromogenic offers flexibility and functionality to researchers who print their own arrays as well as those who purchase ready-to-use arrays and kits.

Alex Vodenlic, president and CEO of Gentel, added that the firm will launch "several" new APiX-based applications covering areas such as animal diagnostics, pathway analysis, cancer research, biomarker discovery, screening, and validation.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.